Successful use of cryocrit for monitoring response to therapeutic plasma exchange in type 1 cryoglobulinemia. Issue 4 (21st July 2015)

• Record Type: Journal Article
• Authors: Olson, Nicholas; Yerrabothala, Swaroopa; Dunbar, Nancy
• Is Part Of: Journal of clinical apheresis. Volume 31:Issue 4(2016)
• Page Start: 403
• Page End: 404
• Publication Date: 2015-07-21
• Subjects: cryoglobulinemia -- cryocrit -- Waldenstrom's macroglobulinemia; Hemapheresis -- Periodicals; Blood -- Transfusion -- Periodicals; Blood -- Transfusion, Autologous -- Periodicals; Cell separation -- Periodicals; Leukapheresis -- Periodicals; Plasmapheresis -- Periodicals; 615.39
• DOI: 10.1002/jca.21414
• Languages: English
• ISSNs: 0733-2459

Abstract

Abstract : Waldenstrom macroglobulinemia (WM) is a clinical syndrome that is defined as lymphoplasmacytic lymphoma with bone marrow involvement and IgM monoclonal gammopathy of any level. In some instances WM can result in a type I cryoglobulinemia with very high cryocrits, which is unusual in type II and III cryoglobulinemia. We describe a case of an 80 year old male with WM, severe type I cryoglobulinemia, and an extremely elevated cryocrit (69%). Over the course of five weeks we performed nine therapeutic plasma exchanges (TPE), and after seven treatments his cryocrit had decreased to 6% with improvement in his symptoms. By monitoring his cryocrit throughout his TPE sessions, we were able to assess his response to treatment, determine the ideal length of treatment in addition to his symptomatic improvement. J. Clin. Apheresis 31:403–404, 2016. © 2015 Wiley Periodicals, Inc.